Title:
SALT OF LSD1 INHIBITOR AND A POLYMORPH THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/015745
Kind Code:
A1
Abstract:
Provided are a compound III serving as an LSD1 inhibitor and a polymorph thereof, as well as an application of the compound and the polymorph thereof in the preparation of drugs for treating LSD1-associated diseases.
Inventors:
ZHAO LELE (CN)
SUN JIANJUN (CN)
WU LINGYUN (CN)
CHEN SHUHUI (CN)
SUN JIANJUN (CN)
WU LINGYUN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2019/096842
Publication Date:
January 23, 2020
Filing Date:
July 19, 2019
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D271/06; A61K31/13; A61P35/00
Domestic Patent References:
WO2018137644A1 | 2018-08-02 | |||
WO2017195216A1 | 2017-11-16 | |||
WO2017184934A1 | 2017-10-26 |
Foreign References:
CN103857393A | 2014-06-11 | |||
CN102947265A | 2013-02-27 | |||
CN201810804068A | 2018-07-20 |
Other References:
ADRIAN BIRD, NATURE, vol. 2007, pages 396 - 398
"Chinese Pharmacopoeia", 2015, article "Guiding Principles for Testing of Stability of API and Preparations"
"Chinese Pharmacopoeia", 2015, article "Guiding Principles for Testing of Stability of API and Preparations"
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: